MemorialCare Heart & Vascular Institute (MHVI) at Saddleback Medical Center is proud to announce today the addition of two ...

Thoracic aortic aneurysms represent a major health problem. Untreated thoracic aortic aneurysms may rupture, which has a dismal outcome. The standard treatment for thoracic aneurysms is open ...

[8] The same classification is followed in thoracic aneurysm repair ... included studies did not consistently report the extent of aortic coverage and location of endografts; hence, we are ...

Endospan today announced the presentation of 30-day results of the statistical Dissection Primary Arm from the TRIOMPHE Investigational Device Exemption (IDE) clinical study evaluating the NEXUS® ...

Endospan today announced the presentation of 30-day results from a study evaluating its Nexus aortic arch stent graft system.

Artivion presents new clinical data from NEXUS TRIOMPHE IDE trial at the 105th AATS Annual Meeting: Atlanta Tuesday, May 6, 2025, 13:00 Hrs [IST] Artivion, Inc., a leading cardiac ...

Endospan announced 30-day results of the statistical Dissection primary arm from the TRIOMPHE investigational device ...

The data were presented during the late-breaking trial session at the American Association for Thoracic ... Aortic Arch Stent-Graft System in patients with aortic arch pathologies (Dissection ...

KMC Hospital, saved the life of Shetty (name changed) who was battling with critically rare and fatal abdominal aortic ...

Abstract: Objective: Computational modelling of ascending thoracic aortic aneurysms (ATAA) typically assumes zerodisplacement at the model's inlet. In this study we incorporated different types of ...